HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by BOEHLEN, F. Articles by DE MOERLOOSE, P. Search for Related Content PubMed PubMed Citation Articles by BOEHLEN, F. Articles by DE MOERLOOSE, P.

Maternal Antiplatelet Antibodies in Predicting Risk of Neonatal Thrombocytopenia

From the Departments of Internal Medicine and Gynecology and Obstetrics, University Hospital, Geneva; and the Department of Gynecology and Obstetrics, University Hospital, Lausanne, Switzerland.

Address reprint requests to: Philippe de Moerloose, MD Hemostasis Unit University Hospital 1211 Geneva 14 Switzerland E-mail: phdm{at}diogenes.hcuge.ch

Objective: To determine the incidence of maternal antiplatelet antibodies in cases of thrombocytopenia during pregnancy, using the monoclonal antibody–specific immobilization of platelet antigens assay; and to assess the usefulness of this assay for predicting risk of neonatal thrombocytopenia.

Methods: A total of 6770 pregnant women were included in the study, and the monoclonal antibody–specific immobilization of platelet antigens assay was done when platelet counts were less than 150 x 10⁹/L. Platelet counts were determined in 6103 newborns.

Results: The incidence of maternal thrombocytopenia was 11.6% (95% confidence interval [CI] 10.8, 12.4). Among newborns, 1.3% (95% CI 0.5, 2.7) born to thrombocytopenic mothers were thrombocytopenic, compared with 0.4% (95% CI 0.2, 0.6) born to nonthrombocytopenic women. Antiplatelet antibodies were detected in 37 (8.6%) of 430 thrombocytopenic women; autoantibodies were detected in 28 cases (circulating or bound to platelets), alloantibodies in eight cases, and an association of alloantibodies and autoantibodies in one case. The positive and negative likelihood ratios for predicting neonatal thrombocytopenia were 4.6 and 0.7, respectively.

Conclusion: The monoclonal antibody–specific immobilization of platelet antigens assay did not predict the risk of neonatal thrombocytopenia in an unselected population of thrombocytopenic pregnant women.

This article has been cited by other articles:

				K. R. McCrae, J. B. Bussel, P. M. Mannucci, G. Remuzzi, and D. B. Cines Platelets: An Update on Diagnosis and Management of Thrombocytopenic Disorders Hematology, January 1, 2001; 2001(1): 282 - 305. [Abstract] [Full Text] [PDF]

				F. BOEHLEN, P. HOHLFELD, P. EXTERMANN, T. V. PERNEGER, and P. DE MOERLOOSE Platelet Count at Term Pregnancy: A Reappraisal of the Threshold Obstet. Gynecol., January 1, 2000; 95(1): 29 - 33. [Abstract] [Full Text] [PDF]